Central vein thrombosis and topical dipivalyl epinephrine.
A report is given on an 83-year-old female who acquired central vein thrombosis in her seeing eye one day after having started topical medication with dipivalyl epinephrine for advanced glaucoma discovered in the other eye. From present knowledge about the effects of adrenergic eye drops on ocular blood circulation, it is difficult to suggest an association between the two events, which may be coincidental only.
Fledelius
H C
HC
Department of Ophthalmology, Hillerød Central Hospital, Denmark.
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D004837:Epinephrine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005654:Fundus Oculi; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D012166:Retinal Hemorrhage / Q000139:chemically induced; D012170:Retinal Vein Occlusion / Q000139:chemically induced*
C015173:dipivefrin; D004837:Epinephrine